Novel Thrombopoietin-Mimetic Peptide 2B9F: A Promising Therapeutic Candidate for Hematopoietic Acute Radiation Syndrome
Open Access
- 15 June 2026
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (25) , 37090-37101
Abstract
Therapeutic interventions for hematopoietic acute radiation syndrome (H-ARS) remain limited in both variety and efficacy, falling short of achieving durable recovery of the hematopoietic system. Here, we develop 2B9F, a novel thrombopoietin-mimetic peptide engineered for enhanced stability and designed with the intention of achieving low immunogenicity. A single subcutaneous dose of 2B9F administered postexposure achieved complete survival in a lethal murine irradiation model, surpassing the efficacy of the clinically approved agent romiplostim. Treatment with 2B9F accelerated the recovery of peripheral blood counts and bone marrow nucleated cells, expanded functional hematopoietic stem cells (HSCs), and enhanced both in vitro clonogenic potential and in vivo competitive repopulation capacity. Mechanistic studies revealed that 2B9F promoted HSC quiescence and survival through transcriptional modulation of apoptosis and cell-cycle regulators. Importantly, a single low dose of 2B9F also conferred durable protection, mitigating delayed bone marrow suppression for up to six months postirradiation. These findings position 2B9F as a promising single-dose, low-immunogenicity therapeutic candidate for H-ARS, indicating strong potential for clinical translation in nuclear emergencies.Keywords
This publication has 34 references indexed in Scilit:
- Dose-optimised recombinant human thrombopoietin versus eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study)eClinicalMedicine, 2025
- Case report:Clinical manifestations and therapeutic options following rhTPO-induced neutralizing antibody production in a child with immune thrombocytopeniaAnnals of Hematology, 2024
- Interleukin‐12 sustained release system promotes hematopoietic recovery after radiation injuryMedcomm, 2024
- Amomum subulatum fruits protect against radiation-induced esophagitis by regulating antioxidant status and inflammatory responsesFood Research International, 2023
- Single-Dose Administration of Recombinant Human Thrombopoietin Mitigates Total Body Irradiation-Induced Hematopoietic System Injury in Mice and Nonhuman PrimatesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2020
- Phenylephrine Alleviates 131I Radiation Damage in Submandibular Gland Through Maintaining Mitochondrial HomeostasisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2019
- An Introduction to Radiation SensibilitiesJournal of the American College of Radiology, 2017
- Exposure to low dose ionising radiation: Molecular and clinical consequencesCancer Letters, 2013
- Bcl-2-regulated apoptosis: mechanism and therapeutic potentialCurrent Opinion in Immunology, 2007
- Molecular biology in radiation therapy: The potential impact of recombinant technology on clinical practiceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994